HK1223555A1 - 用於減少眼內壓的組合物和方法 - Google Patents
用於減少眼內壓的組合物和方法Info
- Publication number
- HK1223555A1 HK1223555A1 HK16111862.4A HK16111862A HK1223555A1 HK 1223555 A1 HK1223555 A1 HK 1223555A1 HK 16111862 A HK16111862 A HK 16111862A HK 1223555 A1 HK1223555 A1 HK 1223555A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- methods
- intraocular pressure
- reducing intraocular
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361912070P | 2013-12-05 | 2013-12-05 | |
PCT/US2014/068671 WO2015085121A1 (en) | 2013-12-05 | 2014-12-04 | Compositions and methods for reducing intraocular pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1223555A1 true HK1223555A1 (zh) | 2017-08-04 |
Family
ID=53274147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16111862.4A HK1223555A1 (zh) | 2013-12-05 | 2016-10-14 | 用於減少眼內壓的組合物和方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US10046001B2 (zh) |
EP (1) | EP3076979B1 (zh) |
JP (1) | JP6548269B2 (zh) |
KR (1) | KR102246113B1 (zh) |
AU (1) | AU2014360369B2 (zh) |
CA (1) | CA2932618A1 (zh) |
HK (1) | HK1223555A1 (zh) |
MX (1) | MX2016007377A (zh) |
WO (1) | WO2015085121A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105044361B (zh) * | 2015-08-14 | 2017-07-28 | 山东省肿瘤防治研究院 | 一种适合于食管鳞状细胞癌早期诊断的诊断标记物及其筛选方法 |
US11369695B2 (en) * | 2016-12-05 | 2022-06-28 | The Jackson Laboratory | Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000004898A1 (en) | 1998-07-21 | 2000-02-03 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
ATE539741T1 (de) * | 2004-11-30 | 2012-01-15 | Tno | Sphingolipide bei der behandlung und prävention von hepatischer steatose |
WO2011138801A1 (en) * | 2010-05-07 | 2011-11-10 | Sun Pharma Advanced Research Company Ltd. | Novel ophthalmic compositions |
US20110294730A1 (en) * | 2010-05-31 | 2011-12-01 | Shantha Totada R | Method of treating glaucoma and intraocular hypertension |
WO2012105674A1 (ja) * | 2011-02-04 | 2012-08-09 | 興和株式会社 | 緑内障予防又は治療のための薬物療法 |
US20130316983A1 (en) | 2012-05-03 | 2013-11-28 | Orasis | Drug screening method, compositions and methods of treating glaucoma |
-
2014
- 2014-12-04 JP JP2016536892A patent/JP6548269B2/ja active Active
- 2014-12-04 US US15/102,201 patent/US10046001B2/en not_active Expired - Fee Related
- 2014-12-04 EP EP14867326.2A patent/EP3076979B1/en active Active
- 2014-12-04 KR KR1020167017531A patent/KR102246113B1/ko active IP Right Grant
- 2014-12-04 WO PCT/US2014/068671 patent/WO2015085121A1/en active Application Filing
- 2014-12-04 CA CA2932618A patent/CA2932618A1/en not_active Abandoned
- 2014-12-04 AU AU2014360369A patent/AU2014360369B2/en active Active
- 2014-12-04 MX MX2016007377A patent/MX2016007377A/es active IP Right Grant
-
2016
- 2016-10-14 HK HK16111862.4A patent/HK1223555A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US10046001B2 (en) | 2018-08-14 |
WO2015085121A9 (en) | 2016-07-21 |
US20160339043A1 (en) | 2016-11-24 |
WO2015085121A1 (en) | 2015-06-11 |
EP3076979A1 (en) | 2016-10-12 |
AU2014360369A1 (en) | 2016-07-07 |
EP3076979A4 (en) | 2017-06-14 |
KR20160095025A (ko) | 2016-08-10 |
CA2932618A1 (en) | 2015-06-11 |
EP3076979B1 (en) | 2020-04-29 |
AU2014360369B2 (en) | 2019-11-07 |
JP2017512182A (ja) | 2017-05-18 |
MX2016007377A (es) | 2016-10-13 |
JP6548269B2 (ja) | 2019-07-24 |
KR102246113B1 (ko) | 2021-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273205A (en) | Preparations and methods | |
IL289821A (en) | Preparations and methods for immunotherapy | |
HK1218837A1 (zh) | 組合物和方法 | |
HK1218560A1 (zh) | 組成與方法 | |
HK1220387A1 (zh) | 用於免疫療法的組合物和方法 | |
GB2533892B (en) | Compositions and methods | |
GB201308072D0 (en) | Compositions and methods | |
IL285527A (en) | Preparations and methods for immunotherapy | |
GB201305414D0 (en) | Method and composition | |
GB201305813D0 (en) | Compositions and methods | |
EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
HK1214131A1 (zh) | 包含氫化可的松的組合物 | |
HK1223555A1 (zh) | 用於減少眼內壓的組合物和方法 | |
PL2815740T3 (pl) | Preparat oftalmologiczny | |
GB201322617D0 (en) | Methods and compositions | |
GB201312393D0 (en) | Compositions and Methods |